Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Cancer|September 15, 1989
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survivalP F Conte, A Alama, A Rubagotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative GroupF Boccardo, A Rubagotti, P Bruzzi, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trialF Boccardo, A Rubagotti, D Amoroso, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The impact of received dose intensity on the outcome of advanced ovarian cancerL Repetto, M Pace, S Mammoliti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian studyF Boccardo, D Cannata, A Rubagotti, et al.American Journal of Clinical Oncology|February 1, 1994
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapyS Chiara, P Conte, P Franzone, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study GroupF Boccardo, M Pace, A Rubagotti, et al.Tumori|February 29, 1984
Endocrine effects of tamoxifen in postmenopausal breast cancer patientsF Boccardo, D Guarneri, A Rubagotti, et al.Cancer|July 1, 1990
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task ForceR Rosso, F Salvati, A Ardizzoni, et al.The Prostate|January 1, 1987
Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) studyF Boccardo, A Decensi, D Guarneri, et al.Pageof 7